RS60565B1 - Postupci za određivanje razlika u aktivnosti alfa-4 integrina putem uspostavljanja korelacije sa razlikama u nivoima svcam i/ili smadcam - Google Patents
Postupci za određivanje razlika u aktivnosti alfa-4 integrina putem uspostavljanja korelacije sa razlikama u nivoima svcam i/ili smadcamInfo
- Publication number
- RS60565B1 RS60565B1 RS20200712A RSP20200712A RS60565B1 RS 60565 B1 RS60565 B1 RS 60565B1 RS 20200712 A RS20200712 A RS 20200712A RS P20200712 A RSP20200712 A RS P20200712A RS 60565 B1 RS60565 B1 RS 60565B1
- Authority
- RS
- Serbia
- Prior art keywords
- differences
- svcam
- alpha
- methods
- correlating
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40635810P | 2010-10-25 | 2010-10-25 | |
US40636510P | 2010-10-25 | 2010-10-25 | |
EP17192860.9A EP3326645B1 (en) | 2010-10-25 | 2011-10-24 | Methods for determining differences in alpha-4 integrin activity by correlating differences in svcam and/or smadcam levels |
Publications (1)
Publication Number | Publication Date |
---|---|
RS60565B1 true RS60565B1 (sr) | 2020-08-31 |
Family
ID=46024768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20200712A RS60565B1 (sr) | 2010-10-25 | 2011-10-24 | Postupci za određivanje razlika u aktivnosti alfa-4 integrina putem uspostavljanja korelacije sa razlikama u nivoima svcam i/ili smadcam |
Country Status (17)
Country | Link |
---|---|
US (3) | US20130337470A1 (sr) |
EP (3) | EP2632492B1 (sr) |
JP (2) | JP5847188B2 (sr) |
AU (4) | AU2011323820A1 (sr) |
CA (1) | CA2816016A1 (sr) |
CY (1) | CY1123060T1 (sr) |
DK (1) | DK3326645T3 (sr) |
ES (2) | ES2800066T3 (sr) |
HK (1) | HK1256157A1 (sr) |
HR (1) | HRP20200920T1 (sr) |
HU (1) | HUE050713T2 (sr) |
LT (1) | LT3326645T (sr) |
PL (1) | PL3326645T3 (sr) |
PT (1) | PT3326645T (sr) |
RS (1) | RS60565B1 (sr) |
SI (1) | SI3326645T1 (sr) |
WO (1) | WO2012061074A1 (sr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012061074A1 (en) | 2010-10-25 | 2012-05-10 | Elan Pharmaceuticals, Inc. | METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS |
MX2017006959A (es) * | 2014-12-02 | 2017-08-10 | Nestec Sa | Metodos para establecer un regimen de dosificacion de vedolizumab para tratar pacientes con enfermedad del intestino irritable. |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US5338689A (en) | 1987-08-24 | 1994-08-16 | Stiftung Fur Diagnostische Forschung | Method and card for detecting antigens and/or antibodies |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US7238668B1 (en) | 1989-09-01 | 2007-07-03 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof |
US5730978A (en) | 1989-09-01 | 1998-03-24 | Fred Hutchinson Cancer Research Center | Inhibition of lymphocyte adherence with α4β1-specific antibodies |
US6033665A (en) | 1989-09-27 | 2000-03-07 | Elan Pharmaceuticals, Inc. | Compositions and methods for modulating leukocyte adhesion to brain endothelial cells |
US5260210A (en) | 1989-09-27 | 1993-11-09 | Rubin Lee L | Blood-brain barrier model |
EP0463151B1 (en) | 1990-01-12 | 1996-06-12 | Cell Genesys, Inc. | Generation of xenogeneic antibodies |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
GB9206318D0 (en) | 1992-03-24 | 1992-05-06 | Cambridge Antibody Tech | Binding substances |
US6172197B1 (en) | 1991-07-10 | 2001-01-09 | Medical Research Council | Methods for producing members of specific binding pairs |
US5858657A (en) | 1992-05-15 | 1999-01-12 | Medical Research Council | Methods for producing members of specific binding pairs |
DE69230142T2 (de) | 1991-05-15 | 2000-03-09 | Cambridge Antibody Technology Ltd. | Verfahren zur herstellung von spezifischen bindungspaargliedern |
US6225447B1 (en) | 1991-05-15 | 2001-05-01 | Cambridge Antibody Technology Ltd. | Methods for producing members of specific binding pairs |
DK0590058T3 (da) | 1991-06-14 | 2004-03-29 | Genentech Inc | Humaniseret heregulin-antistof |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
US5224539A (en) | 1991-06-14 | 1993-07-06 | Coen Company, Inc. | Cooling system for air heaters and the like |
ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
ATE463573T1 (de) | 1991-12-02 | 2010-04-15 | Medimmune Ltd | Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken |
US5872215A (en) | 1991-12-02 | 1999-02-16 | Medical Research Council | Specific binding members, materials and methods |
US5871734A (en) | 1992-01-13 | 1999-02-16 | Biogen, Inc. | Treatment for asthma with VLA-4 blocking agents |
US5932214A (en) | 1994-08-11 | 1999-08-03 | Biogen, Inc. | Treatment for inflammatory bowel disease with VLA-4 blockers |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
EP0672142B1 (en) | 1992-12-04 | 2001-02-28 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
DE69419721T2 (de) | 1993-01-12 | 2000-04-27 | Biogen, Inc. | Rekombinante anti-vla4 antikörpermoleküle |
NZ262615A (en) | 1993-02-09 | 1996-02-27 | Biogen Inc | Treating insulin dependent diabetes (type i) with anti vla4 (very late antigen) antibodies |
US7435802B2 (en) | 1994-01-25 | 2008-10-14 | Elan Pharaceuticals, Inc. | Humanized anti-VLA4 immunoglobulins |
US5840299A (en) | 1994-01-25 | 1998-11-24 | Athena Neurosciences, Inc. | Humanized antibodies against leukocyte adhesion molecule VLA-4 |
GB9406974D0 (en) | 1994-04-08 | 1994-06-01 | Pharmaceutical Proteins Ltd | Transgenic production |
BE1008817A6 (fr) | 1994-10-28 | 1996-08-06 | Univ Bruxelles | Procede d'obtention d'adn bicatenaire membranaire humain, produit obtenu par ce procede et trousse de diagnostic le contenant. |
US6113898A (en) | 1995-06-07 | 2000-09-05 | Idec Pharmaceuticals Corporation | Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies |
GB9712818D0 (en) | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
DE19647381A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Ag | Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten |
PL323130A1 (en) | 1996-11-15 | 1998-05-25 | Hoechst Ag | Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such |
US5965356A (en) | 1997-01-31 | 1999-10-12 | University Of Maryland, Baltimore | Herpes simplex virus type specific seroassay |
US6489300B1 (en) * | 1997-07-31 | 2002-12-03 | Eugene D. Thorsett | Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
DE19741235A1 (de) | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19741873A1 (de) | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19751251A1 (de) | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
WO1999058573A1 (en) * | 1998-05-13 | 1999-11-18 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
US6756378B2 (en) | 1999-06-30 | 2004-06-29 | Pharmacopeia Drug Discovery, Inc. | VLA-4 inhibitor compounds |
KR20020067050A (ko) | 1999-12-28 | 2002-08-21 | 화이자 프로덕츠 인코포레이티드 | 염증성, 자기면역 및 호흡기 질환의 치료에 유용한브이엘에이-4 의존성 세포 결합의 비펩티드계 억제제 |
JP5113314B2 (ja) * | 2000-09-01 | 2013-01-09 | ザ センター フォー ブラッド リサーチ インク | 所望のコンホメーションで安定させた改変ポリペプチド及び該ポリペプチドの作製方法 |
DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE10137595A1 (de) | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
PT1485127E (pt) | 2002-02-25 | 2011-09-07 | Elan Pharm Inc | Administração de agentes para o tratamento de inflamação |
UY28170A1 (es) | 2003-01-24 | 2004-07-30 | Elan Pharm Inc | Preparacion y tratamiento para las enfermedades desmielinizantes y paralisis mediante la aplicacion de agentes remielinizantes. |
EP3777880A1 (en) | 2003-02-10 | 2021-02-17 | Biogen MA Inc. | Immunoglobulin formulation and method of preparation thereof |
CA2555365A1 (en) | 2004-02-06 | 2005-08-25 | Elan Pharmaceuticals, Inc. | Methods and compositions for treating tumors and metastatic disease |
WO2005097162A2 (en) | 2004-04-01 | 2005-10-20 | Elan Pharmaceuticals, Inc. | Steroid sparing agents and their use |
MY162179A (en) | 2004-04-01 | 2017-05-31 | Elan Pharm Inc | Steroid sparing agents and methods of using same |
US7196112B2 (en) | 2004-07-16 | 2007-03-27 | Biogen Idec Ma Inc. | Cell adhesion inhibitors |
EP1871806A2 (en) | 2005-03-08 | 2008-01-02 | Pharmacia & Upjohn Company LLC | ANTI-MAdCAM ANTIBODY COMPOSITIONS |
LT2645106T (lt) * | 2005-04-04 | 2017-09-11 | Biogen Ma Inc. | Imuninio atsako į terapinį agentą įvertinimo būdai |
WO2007100770A2 (en) | 2006-02-28 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Methods of treating inflammatory and autoimmune diseases with natalizumab |
SG170058A1 (en) | 2006-03-03 | 2011-04-29 | Elan Pharm Inc | Methods of treating inflammatory and autoimmune diseases with natalizumab |
CA2708262A1 (en) | 2007-12-07 | 2009-06-18 | Elan Pharmaceuticals, Inc. | Methods and compositions for treating liquid tumors |
US20100255508A1 (en) * | 2008-05-16 | 2010-10-07 | Thomas Richard Gelzleichter | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
WO2009141786A2 (en) | 2008-05-21 | 2009-11-26 | Piramal Life Sciences Limited | Anti-inflammatory compounds |
WO2010053316A2 (en) | 2008-11-06 | 2010-05-14 | Snu R&Db Foundation | New use of sixth immunoglobulin-like domain of vcam-1 |
NZ577731A (en) * | 2009-06-16 | 2010-08-27 | Innate Therapeutics Ltd | Compositions and methods for treatment of multiple sclerosis |
WO2011137418A1 (en) * | 2010-04-30 | 2011-11-03 | Elan Pharmaceuticals, Inc. | Selective integrin inhibitors |
WO2012061074A1 (en) | 2010-10-25 | 2012-05-10 | Elan Pharmaceuticals, Inc. | METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN sVCAM AND/OR sMAdCAM LEVELS |
-
2011
- 2011-10-24 WO PCT/US2011/057519 patent/WO2012061074A1/en active Application Filing
- 2011-10-24 US US13/881,520 patent/US20130337470A1/en not_active Abandoned
- 2011-10-24 PL PL17192860T patent/PL3326645T3/pl unknown
- 2011-10-24 DK DK17192860.9T patent/DK3326645T3/da active
- 2011-10-24 ES ES17192860T patent/ES2800066T3/es active Active
- 2011-10-24 JP JP2013536701A patent/JP5847188B2/ja active Active
- 2011-10-24 AU AU2011323820A patent/AU2011323820A1/en not_active Abandoned
- 2011-10-24 EP EP11838481.7A patent/EP2632492B1/en active Active
- 2011-10-24 CA CA2816016A patent/CA2816016A1/en active Pending
- 2011-10-24 HU HUE17192860A patent/HUE050713T2/hu unknown
- 2011-10-24 EP EP20162844.3A patent/EP3722808A1/en active Pending
- 2011-10-24 EP EP17192860.9A patent/EP3326645B1/en active Active
- 2011-10-24 PT PT171928609T patent/PT3326645T/pt unknown
- 2011-10-24 LT LTEP17192860.9T patent/LT3326645T/lt unknown
- 2011-10-24 ES ES11838481.7T patent/ES2654820T3/es active Active
- 2011-10-24 SI SI201131889T patent/SI3326645T1/sl unknown
- 2011-10-24 RS RS20200712A patent/RS60565B1/sr unknown
-
2014
- 2014-02-19 HK HK18115240.6A patent/HK1256157A1/zh unknown
-
2015
- 2015-08-27 JP JP2015167690A patent/JP2015215363A/ja not_active Withdrawn
-
2016
- 2016-04-18 US US15/131,804 patent/US11079393B2/en active Active
-
2017
- 2017-03-10 AU AU2017201658A patent/AU2017201658B2/en active Active
-
2019
- 2019-06-12 AU AU2019204089A patent/AU2019204089A1/en not_active Abandoned
-
2020
- 2020-06-08 HR HRP20200920TT patent/HRP20200920T1/hr unknown
- 2020-06-17 CY CY20201100555T patent/CY1123060T1/el unknown
-
2021
- 2021-08-03 US US17/393,267 patent/US20220206012A1/en active Pending
- 2021-08-05 AU AU2021212059A patent/AU2021212059A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
LT3326645T (lt) | 2020-08-10 |
EP2632492A1 (en) | 2013-09-04 |
JP2015215363A (ja) | 2015-12-03 |
EP3326645B1 (en) | 2020-03-18 |
HK1256157A1 (zh) | 2019-09-13 |
AU2017201658A1 (en) | 2017-03-30 |
AU2017201658B2 (en) | 2019-03-21 |
WO2012061074A1 (en) | 2012-05-10 |
EP2632492B1 (en) | 2017-10-04 |
CY1123060T1 (el) | 2021-10-29 |
US20220206012A1 (en) | 2022-06-30 |
PL3326645T3 (pl) | 2020-09-21 |
AU2019204089A1 (en) | 2019-07-04 |
AU2011323820A1 (en) | 2013-05-23 |
US20160291035A1 (en) | 2016-10-06 |
EP3326645A1 (en) | 2018-05-30 |
EP3722808A1 (en) | 2020-10-14 |
JP5847188B2 (ja) | 2016-01-20 |
EP2632492A4 (en) | 2014-04-02 |
SI3326645T1 (sl) | 2020-09-30 |
HRP20200920T1 (hr) | 2020-10-30 |
ES2800066T3 (es) | 2020-12-23 |
PT3326645T (pt) | 2020-06-23 |
AU2021212059A1 (en) | 2021-08-26 |
HUE050713T2 (hu) | 2020-12-28 |
ES2654820T3 (es) | 2018-02-15 |
US20130337470A1 (en) | 2013-12-19 |
CA2816016A1 (en) | 2012-05-10 |
DK3326645T3 (da) | 2020-06-15 |
JP2014500950A (ja) | 2014-01-16 |
US11079393B2 (en) | 2021-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2700061A4 (en) | SYSTEMS AND METHOD FOR ANALYZING ENERGY CONSUMPTION | |
HK1206065A1 (en) | Compositions and methods for analyte detection | |
HK1193471A1 (zh) | 識別和測量網狀細胞 | |
GB2516204B (en) | Multi-cue object detection and analysis | |
EP2673631A4 (en) | METHOD AND SYSTEMS FOR DETERMINING THE PRESENCE OR QUANTITY OF TESTOSTERONE IN A SAMPLE | |
SG11201401913YA (en) | Systems and methods for biological analysis | |
EP2456361A4 (en) | SYSTEMS FOR CONTINUOUS ANALYTING MEASUREMENT AND SYSTEMS AND METHOD FOR THE IMPLEMENTATION THEREOF | |
EP2683810A4 (en) | METHOD AND SYSTEM FOR CELL DETECTION AND ANALYSIS | |
SG11201401016YA (en) | Web inspection calibration system and related methods | |
EP2663864A4 (en) | IMMUNODIVERSITY QUICK PROCEDURE AND ITS APPLICATION | |
SG11201401956XA (en) | Undifferentiated cell detection method and complex carbohydrate detection method | |
EP2553657A4 (en) | METHODS AND APPARATUS FOR FACIAL DETECTION | |
EP2703494A4 (en) | CELL ANALYSIS METHOD, DEVICE AND PROGRAM | |
EP2584964A4 (en) | SYSTEMS AND METHODS FOR MONITORING SUBSTANCE TO BE ANALYZED | |
EP2705135A4 (en) | SYSTEMS AND METHODS FOR ANALYZING BASOPHILES | |
ZA201208522B (en) | Methods for measuring enzyme activity useful in determining cell viability in non-purified sapmles | |
IL222752A0 (en) | Acoustic methods and systems for detecting terahertz radioation | |
EP2533049A4 (en) | PRETREATMENT SOLUTION FOR IMMUNOHISTOCHEMICAL COLORING AND CONDENSED SOLUTION THEREOF | |
EP2788794A4 (en) | PERMEABILITY PREDICTION SYSTEMS AND METHODS INVOLVING QUADRATIC DISCRIMINANT ANALYSIS | |
EP2612256A4 (en) | IMPLEMENTATION OF »WHAT-IF-ANALYSIS | |
EP2726813A4 (en) | SURFACE MEASURING SYSTEM AND METHOD | |
EP2650875A4 (en) | PITCH ORDER DETERMINATION DEVICE, TRACK ORDER DETERMINATION METHOD, AND TRACK ORDER DETERMINATION PROGRAM | |
EP2640407A4 (en) | PROCESS FOR INCREASING THE EXPRESSION AND ACTIVITY OF NEPRILYSIN | |
EP2576809A4 (en) | MEASURE A YEAST CONCENTRATION AND LIFE CAPABILITY | |
EP2553115A4 (en) | METHODS OF CULTURE AND ANALYSIS OF CELLS |